KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 156,089 Value ($000) $415 Avg Close — Range —
Q4 2023
Shares 194,468 Value ($000) $461 Avg Close — Range —
Q3 2023
Shares 84,148 Value ($000) $118 Avg Close — Range —
Q2 2023
Shares 108,450 Value ($000) $329 Avg Close — Range —
Q4 2022
Shares 14,944 Value ($000) $91 Avg Close — Range —
Q3 2022
Shares 11,452 Value ($000) $137 Avg Close — Range —